| scholarly article | Q13442814 |
| P50 | author | W. Mark Saltzman | Q23092145 |
| Steven M. Jay | Q43855197 | ||
| P2093 | author name string | Jordan S Pober | |
| Themis R Kyriakides | |||
| Benjamin R Shepherd | |||
| Jillian W Andrejecsk | |||
| P2860 | cites work | Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP) | Q28115465 |
| A perivascular origin for mesenchymal stem cells in multiple human organs | Q28131808 | ||
| Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2 | Q28187887 | ||
| Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration | Q28207902 | ||
| Endogenous VEGF-A is responsible for mitogenic effects of MCP-1 on vascular smooth muscle cells | Q28570673 | ||
| Monocyte and macrophage heterogeneity | Q29547438 | ||
| Molecular regulation of vessel maturation | Q29614540 | ||
| Material-based deployment enhances efficacy of endothelial progenitor cells. | Q30484065 | ||
| Unchain my heart: the scientific foundations of cardiac repair | Q33683767 | ||
| Induction, differentiation, and remodeling of blood vessels after transplantation of Bcl-2-transduced endothelial cells. | Q33722822 | ||
| Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model | Q34125421 | ||
| Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals | Q34575418 | ||
| The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation | Q35103605 | ||
| Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization | Q35111623 | ||
| In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse | Q35199743 | ||
| Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression | Q35745301 | ||
| Foreign body giant cell formation is preceded by lamellipodia formation and can be attenuated by inhibition of Rac1 activation. | Q35916038 | ||
| Angiogenic growth factor synergism in a murine tissue engineering model of angiogenesis and adipogenesis | Q36202920 | ||
| Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation | Q36804985 | ||
| Recruitment of the inflammatory subset of monocytes to sites of ischemia induces angiogenesis in a monocyte chemoattractant protein-1-dependent fashion | Q36838523 | ||
| Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking | Q37182599 | ||
| Paradoxical effects of PDGF-BB overexpression in endothelial cells on engineered blood vessels in vivo | Q37257180 | ||
| Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial | Q38522489 | ||
| A role for VEGF as a negative regulator of pericyte function and vessel maturation | Q39919369 | ||
| Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis | Q40553670 | ||
| Tissue engineering: creation of long-lasting blood vessels | Q40579851 | ||
| Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression | Q40868885 | ||
| Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease | Q41105403 | ||
| Human aortic smooth muscle cells promote arteriole formation by coengrafted endothelial cells. | Q43131926 | ||
| Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies | Q43601317 | ||
| Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation | Q44138410 | ||
| Spatial and temporal control of angiogenesis and arterialization using focal applications of VEGF164 and Ang-1. | Q44646897 | ||
| The dosage dependence of VEGF stimulation on scaffold neovascularisation | Q46785222 | ||
| Effects of local MCP-1 protein therapy on the development of the collateral circulation and atherosclerosis in Watanabe hyperlipidemic rabbits | Q46897828 | ||
| Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells | Q47595908 | ||
| MCP-1-dependent signaling in CCR2(-/-) aortic smooth muscle cells | Q47951170 | ||
| The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis | Q48011091 | ||
| Alloimmunity to human endothelial cells derived from cord blood progenitors. | Q50859678 | ||
| In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. | Q51059546 | ||
| Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. | Q51083232 | ||
| Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. | Q51171496 | ||
| Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway. | Q53600580 | ||
| Monocyte Chemotactic Protein-1 Increases Collateral and Peripheral Conductance After Femoral Artery Occlusion | Q60495153 | ||
| Improvement of contractility accompanies angiogenesis rather than arteriogenesis in chronic myocardial ischemia | Q63258728 | ||
| The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis | Q73139585 | ||
| Is host endothelium a silver lining for allografts? | Q73485787 | ||
| Polymeric system for dual growth factor delivery | Q77106419 | ||
| Release from alginate enhances the biological activity of vascular endothelial growth factor | Q77708503 | ||
| Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1 | Q78728296 | ||
| The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization | Q83202158 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 11 | |
| P921 | main subject | endothelium | Q111140 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 3054-3062 | |
| P577 | publication date | 2010-01-27 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Dual delivery of VEGF and MCP-1 to support endothelial cell transplantation for therapeutic vascularization | |
| P478 | volume | 31 |
| Q38084737 | Alginate-based strategies for therapeutic vascularization |
| Q34236679 | Alginate: properties and biomedical applications |
| Q27306849 | Analyzing Structure and Function of Vascularization in Engineered Bone Tissue by Video-Rate Intravital Microscopy and 3D Image Processing |
| Q34766733 | Biomaterial constructs for delivery of multiple therapeutic genes: a spatiotemporal evaluation of efficacy using molecular beacons |
| Q52399862 | Biomaterial-driven in situ cardiovascular tissue engineering-a multi-disciplinary perspective. |
| Q30426452 | Biomedical Applications of Biodegradable Polymers |
| Q41538962 | Calcium-alginate hydrogel-encapsulated fibroblasts provide sustained release of vascular endothelial growth factor |
| Q38172390 | Cardiac tissue engineering: renewing the arsenal for the battle against heart disease |
| Q38021440 | Cardiovascular biomaterials: when the inflammatory response helps to efficiently restore tissue functionality? |
| Q35162409 | Controlled protein delivery in the generation of microvascular networks. |
| Q37995298 | Delivering bioactive molecules as instructive cues to engineered tissues |
| Q37885356 | Delivery approaches for angiogenic growth factors in the treatment of ischemic conditions |
| Q37169254 | Direct-write bioprinting three-dimensional biohybrid systems for future regenerative therapies |
| Q37870320 | Engineered cardiac tissues |
| Q89446792 | Enzymatically degradable alginate hydrogel systems to deliver endothelial progenitor cells for potential revasculature applications |
| Q36089708 | Genetically modified human placenta‑derived mesenchymal stem cells with FGF‑2 and PDGF‑BB enhance neovascularization in a model of hindlimb ischemia |
| Q37960809 | Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications. |
| Q38658691 | Mechanistic and therapeutic overview of glycosaminoglycans: the unsung heroes of biomolecular signaling. |
| Q99604962 | Microbial Exopolysaccharides as Drug Carriers |
| Q36981636 | Monocytes and macrophages in tissue repair: Implications for immunoregenerative biomaterial design |
| Q37340560 | Paracrine exchanges of molecular signals between alginate-encapsulated pericytes and freely suspended endothelial cells within a 3D protein gel. |
| Q92660694 | Peripheral blood mononuclear cells extracts VEGF protein levels and VEGF mRNA: Associations with inflammatory molecules in a healthy population |
| Q41878827 | Pigment epithelium-derived factor restoration increases bone mass and improves bone plasticity in a model of osteogenesis imperfecta type VI via Wnt3a blockade |
| Q35892487 | Regenerative medicine as applied to general surgery |
| Q42987671 | Shear flow affects selective monocyte recruitment into MCP-1-loaded scaffolds |
| Q39175995 | Spatiotemporal control of vascular endothelial growth factor expression using a heat-shock-activated, rapamycin-dependent gene switch |
| Q38124263 | Stem cells for cardiac repair: an introduction |
| Q37503636 | Sustained delivery of proangiogenic microRNA-132 by nanoparticle transfection improves endothelial cell transplantation. |
| Q36418634 | Temporally tunable, enzymatically responsive delivery of proangiogenic peptides from poly(ethylene glycol) hydrogels |
| Q37049626 | Transdermal regulation of vascular network bioengineering using a photopolymerizable methacrylated gelatin hydrogel |
| Q38846610 | Using Del-1 to tip the angiogenic balance in endothelial cells in modular constructs |
| Q38022017 | Vascular endothelial growth factor-delivery systems for cardiac repair: an overview. |
Search more.